Carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
AssigneeMerrell Dow Pharmaceuticals Inc.
InventorsAlan M. Warshawsky, Gary A. Flynn
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerrell Dow Pharmaceuticals Inc.
InventorsAlan M. Warshawsky, Gary A. Flynn
Estimating the term…
The invention relates to compounds of the formula ##STR1## wherein B.sub.1 and B.sub.2 are each independently hydrogen; hydroxy; --OR.sub.2 wherein R.sub.2 is a C.sub.1 -C.sub.4 alkyl or an Ar--Y group wherein Ar is aryl and Y is a hydrogen or C.sub.1 -C.sub.4 alkyl; or, where B.sub.1 and B.sub.2 are attached to adjacent carbon atoms, B.sub.1 and B.sub.2 can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; A is a bond, methylene or oxygen, sulfur, NR.sub.4 or NCOR.sub.5 wherein R.sub.4 is hydrogen, a C.sub.1 -C.sub.4 alkyl or an Ar--Y-- group and R.sub.5 is --CF.sub.3, a C.sub.1 -C.sub.10 alkyl or an Ar--Y-- group; R.sub.3 is hydrogen or --CH.sub.2 OC(O)C(CH.sub.3).sub.3 ; R.sub.1 is hydrogen, C.sub.1 -C.sub.4 alkyl or --CH.sub.2 OC(O)--C(CH.sub.3).sub.3 ; and n is an integer 1 to 3, that are useful as inhibitors of enkephalinase and ACE.
A method of inhibiting ACE in a patient in need thereof comprising administering to said patient an effective ACE inhibitory amount of a compound of the formula ##STR10## wherein B.sub.1 and B.sub.2 are each independently hydrogen;
Dependencies are inferred from the claim text.